Trial intelligence / Profile preview

Eltrombopag plus Cyclosporin A in Egyptian Patients with Aplastic Anemia

NCT03896971Phase 4Completed

Start
Nov 2019
Primary completion
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of eltrombopag in aplastic anemia. Started Nov 2019; status: completed.

02

Drugs

eltrombopag
03

Conditions

aplastic anemia

Beyond the preview

Go deeper on NCT03896971.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03896971.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call